Skip Navigation

Vaccine Safety Bibliography - October 2013

1. Influenza vaccination coverage among pregnant women - United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2013 Sep 27;62(38):787-92.

2. Influenza vaccination coverage among health-care personnel - United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2013 Sep 27;62(38):781-6.

3. Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions - United States, 2011-12 influenza season. MMWR Morb Mortal Wkly Rep. 2013 Sep 13; 62(36):744-6.

4. Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne J, Fine P, Smith P, Lipman M, Elliman D, Watson J, Drumright L, Whiting P, Vynnycky E, Rodrigues L. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol Assess. 2013 Sep; 17(37):1-372.

5. Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L. Effect of Influenza Vaccination of Health Care Personnel on Morbidity and Mortality among Patients: Systematic Review and Grading of Evidence. Clin Infect Dis. 2013 Sep 17. [Epub ahead of print].

6. Aikawa N, Trudes G, Campos L, Pereira R, Moraes J, Ribeiro A, Miraglia J, Timenetsky MD, Bonfa E, Silva C. Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients. Lupus. 2013 Sep 27. [Epub ahead of print].

7. Al-Hello H, Jorba J, Blomqvist S, Raud R, Kew O, Roivainen M. Highly Divergent Types 2 and 3 Vaccine-Derived Polioviruses Isolated from Sewage in Tallinn, Estonia. J Virol. 2013 Sep 18. [Epub ahead of print].

8. Allison MA, Dunne EF, Markowitz LE, O'Leary ST, Crane LA, Hurley LP, Stokley S, Babbel CI, Brtnikova M, Beaty BL, Kempe A. HPV Vaccination of Boys in Primary  Care Practices. Acad Pediatr. 2013 Sep-Oct; 13(5):466-74.

9. Almazán F, Dediego ML, Sola I, Zuñiga S, Nieto-Torres JL, Marquez-Jurado S, Andrés G, Enjuanes L. Engineering a replication-competent, propagation-defective  middle East respiratory syndrome coronavirus as a vaccine candidate. MBio. 2013 Sep 10; 4(5).

10. Almeida ST, de Lencastre H, Sá-Leão R. Epidemiology and Population Structure  of Serotypes 1, 5 and 7F Carried by Children in Portugal from 1996-2010 before Introduction of the 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines. PLoS One. 2013 Sep 18; 8(9):e75442.

11. Andrew P, Lee W. Innate Immunity and Vaccines. Curr Top Med Chem. 2013 Sep 25. [Epub ahead of print].

12. Assis AS, Valle DA, Antunes GR, Tibiriça SH, Assis RM, Leite JP, Carvalho IP, Rosa E Silva ML. Rotavirus epidemiology before and after vaccine introduction. J  Pediatr (Rio J). 2013 Sep-Oct; 89(5):470-6.

13. Asturias EJ, Contreras-Roldan IL, Ram M, Garcia-Melgar AJ, Morales-Oquendo V, Hartman K, Rauscher M, Moulton LH, Halsey NA. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children. Vaccine. 2013 Sep 18. [Epub ahead of print].

14. Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H; for the Pneumococcal Carriage Group (PneumoCarr). Colonisation endpoints in Streptococcus pneumoniae vaccine trials. Vaccine. 2013 Sep 7. [Epub ahead of print].

15. Avci FY. Novel Strategies for Development of Next-Generation Glycoconjugate Vaccines. Curr Top Med Chem. 2013 Sep 25. [Epub ahead of print].

16. Baty SA, Ayala A, Odish M, Cadwell BL, Schumacher M, Sunenshine RH. Factors associated with receipt of 2009 pandemic influenza A (H1N1) monovalent and seasonal influenza vaccination among school-aged children: Maricopa County, Arizona, 2009-2010 influenza season. J Public Health Manag Pract. 2013 Sep-Oct;19(5):436-43.

17. Bean SJ, Catania JA. Vaccine perceptions among Oregon health care providers.  Qual Health Res. 2013 Sep;23(9):1251-66.

18. Bellia C, Setbon M, Zylberman P, Flahault A. Healthcare worker compliance with seasonal and pandemic influenza vaccination. Influenza Other Respi Viruses.  2013 Sep; 7 Suppl 2:97-104.

19. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect: nonspecific  immunomodulation by vaccines. Trends Immunol. 2013 Sep;34(9):431-9.

20. Bennett L. Vaccines in trials for nicotine cessation therapy. JAAPA. 2013 Sep; 26(9):55-6.

21. Betsch C, Böhm R, Korn L. Inviting free-riders or appealing to prosocial behavior? Game-theoretical reflections on communicating herd immunity in vaccine advocacy. Health Psychol. 2013 Sep; 32(9):978-85.

22. Betsch C. [The role of the Internet in eliminating infectious diseases : Managing perceptions and misperceptions of vaccination]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep; 56(9):1279-86.

23. Bielicki JA, Achermann R, Berger C. In touch but not up-to-date: Ambulatory visits and vaccination status in a cohort of young Swiss children. Vaccine. 2013  Sep 26. [Epub ahead of print].

24. Borrow R, Abad R, Trotter C, van der Klis FR, Vazquez JA. Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine. 2013 Sep 23;31(41):4477-86.

25. Breteler JK, Tam JS, Jit M, Ket JC, De Boer MR. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: A systematic review and meta analysis. Vaccine. 2013 Sep 5. [Epub ahead of print].

26. Brunson EK. How parents make decisions about their children's vaccinations. Vaccine. 2013 Sep 25. [Epub ahead of print].

27. Burke ML, Veer MD, Pleasance J, Neeland M, Elhay M, Harrison P, Meeusen E. Innate immune pathways in afferent lymph following vaccination with poly(I:C)-containing liposomes. Innate Immun. 2013 Sep 17. [Epub ahead of print].

28. Buyse H, Vinals C, Karkada N, Htay Han H. The human rotavirus vaccine RotarixTM in infants: An integrated analysis of safety and reactogenicity. Hum Vaccin Immunother. 2013 Sep 18; 10(1). [Epub ahead of print].

29. Bynum SA, Staras SA, Malo TL, Giuliano AR, Shenkman E, Vadaparampil ST. Factors Associated With Medicaid Providers' Recommendation of the HPV Vaccine to  Low-Income Adolescent Girls. J Adolesc Health. 2013 Sep 21. [Epub ahead of print].

30. Calavia Garsaball O, Otero Romero S, Campins Martí M, Martínez-Gómez X, Rodrigo Pendas JA, Armadans Gil L. [Travelers attending an international vaccine  center. Is the risk for the pediatric traveler increasing?]. An Pediatr (Barc). 2013 Sep; 79(3):142-8.

31. Calo WA, Fernández ME, Fernández-Espada N, Colón-López V. Exploring the Role  of Ethnic Identity on the Attitudes Towards HPV Vaccine Advertising Among Puerto  Ricans: A Qualitative Analysis. J Immigr Minor Health. 2013 Sep 20. [Epub ahead of print].

32. Caplan A. Liberty has its responsibilities: Holding non-vaccinators liable for the harm they do. Hum Vaccin Immunother. 2013 Sep 6; 9(12). [Epub ahead of print].

33. Caskey RN, Macario E, Johnson DC, Hamlish T, Alexander KA. A School-Located Vaccination Adolescent Pilot Initiative in Chicago: Lessons Learned. J Pediatric  Infect Dis Soc. 2013 Sep;2(3):198-204.

34. Castilla J, Martínez-Baz I, Godoy P, Toledo D, Astray J, García S, Mayoral JM, Martín V, González-Candelas F, Guevara M, Diaz-Borrego J, Torner N, Baricot M, Tamames S, Domínguez A; CIBERESP Working Group for the Survey on Influenza Vaccination in Primary Healthcare Professionals. Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008-2011. Prev Med. 2013 Sep;57(3):206-11.

35. Chambers CD, Johnson D, Xu R, Luo Y, Louik C, Mitchell AA, Schatz M, Jones KL; the OTIS Collaborative Research Group. Risks and safety of pandemic h1n1 influenza vaccine in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine. 2013 Sep 7. [Epub ahead of print].

36. Chang WC, Yen C, Chi CL, Wu FT, Huang YC, Lin JS, Huang FC, Tate JE, Wu HS, Hsiung CA. Cost-effectiveness of rotavirus vaccination programs in Taiwan. Vaccine. 2013 Sep 20. [Epub ahead of print].

 37. Chao A, Huang YC, Chang YL, Wang TH, Chang SD, Wu TS, Wu TL, Chao AS. Seroprevalence of influenza A H1N1 and seroconversion of mothers and infants induced by a single dose of monovalent vaccine. Taiwan J Obstet Gynecol. 2013 Sep; 52(3):356-9.

38. Choe YJ, Yang JJ, Park SK, Choi EH, Lee HJ. Comparative Estimation of Coverage between National Immunization Program Vaccines and Non-NIP Vaccines in Korea. J Korean Med Sci. 2013 Sep;28(9):1283-8.

39. Chyu KY, Shah PK. Can We Vaccinate Against Atherosclerosis? J Cardiovasc Pharmacol Ther. 2013 Sep 13. [Epub ahead of print].

40. Ciglenecki I, Sakoba K, Luquero FJ, Heile M, Itama C, Mengel M, Grais RF, Verhoustraeten F, Legros D. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med. 2013 Sep; 10(9):e1001512.

41. Cottin P, Niedrig M, Domingo C. Safety profile of the yellow fever vaccine Stamaril®: a 17-year review. Expert Rev Vaccines. 2013 Sep 25. [Epub ahead of print].

42. Cozzi R, Scarselli M, Ferlenghi I. Structural Vaccinology: A Three-Dimensional View For Vaccine Development. Curr Top Med Chem. 2013 Sep 25. [Epub ahead of print].

43. Croney CM, Nahm MH, Juhn SK, Briles DE, Crain MJ. Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following use of conjugate vaccine. Clin Vaccine Immunol. 2013 Sep 4. [Epub ahead of print].

44. Crowley KA, Myers R, Magda LA, Morse SS, Brandt-Rauf P, Gershon RR. Prevalence and factors associated with 2009 to 2011 influenza vaccinations at a university medical center. Am J Infect Control. 2013 Sep;41(9):824-30.

45. Daly ER, Anderson L, Dreisig J, Dionne-Odom J. Decrease in Varicella Incidence After Implementation of the 2-dose Recommendation for Varicella Vaccine in New Hampshire. Pediatr Infect Dis J. 2013 Sep;32(9):981-3.

46. Dar O, Gobin M, Hogarth S, Lane C, Ramsay M. Mapping the Gypsy Traveller community in England: what we know about their health service provision and childhood immunization uptake. J Public Health (Oxf). 2013 Sep;35(3):404-12.

47. Daugla D, Gami J, Gamougam K, Naibei N, Mbainadji L, Narbé M, Toralta J, Kodbesse B, Ngadoua C, Coldiron M, Fermon F, Page AL, Djingarey M, Hugonnet S, Harrison O, Rebbetts L, Tekletsion Y, Watkins E, Hill D, Caugant D, Chandramohan  D, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Trotter C, Stuart J, Maiden M, Greenwood B. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT)  on serogroup A meningococcal meningitis and carriage in Chad: a community trial.  Lancet. 2013 Sep 11. [Epub ahead of print].

48. Dayan GH, Thakur M, Boaz M, Johnson C. Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA. Vaccine. 2013 Sep 7. [Epub  ahead of print].

49. De Serres G, Skowronski D, Wu X, Ambrose C. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill. 2013 Sep 12; 18(37).

50. de Souza IM, da Silva MN, Figueira ES, Leal MD, Jessouroun E, Pereira Abrantes SD, da Silveira IA. Single Validation of CE method for determining free  polysaccharide content in a Brazilian meningococcal C conjugate vaccine. Electrophoresis. 2013 Sep 3. [Epub ahead of print].

51. de Whalley PC, Snape MD, Plested E, Thompson B, Nuthall E, Omar O, Borrow R,  Pollard AJ. Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination. Arch Dis Child. 2013 Sep; 98(9):686-91.

52. Deshpande M, Schauer J, Mott DA, Young HN, Cory P. Parents' perceptions of pharmacists as providers of influenza vaccine to children. J Am Pharm Assoc (2003). 2013 Sep 1; 53(5):488-95.

53. Di Pilato M, Mejías-Pérez E, Gómez CE, Perdiguero B, Sánchez-Sorzano CO, Esteban M. New vaccinia virus promoter as potential candidate for future vaccines. J Gen Virol. 2013 Sep 28. [Epub ahead of print].

54. Diekema DS. Provider dismissal of vaccine-hesitant families: Misguided policy that fails to benefit children. Hum Vaccin Immunother. 2013 Sep 6;9(12). [Epub ahead of print].

55. Diez-Domingo J, Gurtman A, Bernaola E, Gimenez-Sanchez F, Martinon-Torres F,  Pineda-Solas V, Delgado A, Infante-Marquez P, Liang JZ, Giardina PC, Gruber WC, Emini EA, Scott DA. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain. Vaccine. 2013 Sep 1. [Epub ahead of print].

56. Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P,  Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Sanchez FG, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013 Sep 13;31(40):4448-58.

57. Dolan GP, Harris RC, Clarkson M, Sokal R, Morgan G, Mukaigawara M, Horiuchi H, Hale R, Stormont L, Béchard-Evans L, Chao YS, Eremin S, Martins S, Tam J, Peñalver J, Zanuzadana A, Nguyen-Van-Tam JS. Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review. Influenza Other Respi Viruses. 2013 Sep; 7 Suppl 2:93-6.

58. Donegan K, Beau-Lejdstrom R, King B, Seabroke S, Thomson A, Bryan P. Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine. 2013 Sep 1. [Epub ahead of print].

59. Donkor ES, Dayie NT, Badoe EV. Vaccination against pneumococcus in West Africa: perspectives and prospects. Int J Gen Med. 2013 Sep 11; 6:757-64.

60. Du L, Zhao G, Kou Z, Ma C, Sun S, Poon VK, Lu L, Wang L, Debnath AK, Zheng BJ, Zhou Y, Jiang S. Identification of a receptor-binding domain in the s protein of the novel human coronavirus middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol. 2013 Sep; 87(17):9939-42.

61. Duclos P, Dumolard L, Abeysinghe N, Adjagba A, Janusz CB, Mihigo R, Mosina L, Takashima Y, Oztürk MH. Progress in the establishment and strengthening of national immunization technical advisory groups: Analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012. Vaccine. 2013 Sep 19. [Epub ahead of print].

62. Englund H, Campe H, Hautmann W. Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. Epidemiol Infect. 2013 Sep; 141(9):1807-15.

63. Escolano S, Hill C, Tubert-Bitter P. A New Self-Controlled Case Series Method for Analyzing Spontaneous Reports of Adverse Events After Vaccination. Am J Epidemiol. 2013 Sep 7. [Epub ahead of print].

64. Esposito S, Musio A, Principi N. Paediatric asthma and pneumococcal vaccination. Vaccine. 2013 Sep 8. [Epub ahead of print].

65. Esposito S, Salvini F, Menni F, Scala A, Salvatici E, Manzoni F, Riva E, Giovannini M, Principi N. Preliminary data on immunogenicity, safety and tolerability of trivalent inactivated influenza vaccine in children with inborn errors of metabolism at risk of decompensation. Vaccine. 2013 Sep 5. [Epub ahead of print].

66. Even-Or O, Samira S, Ellis R, Kedar E, Barenholz Y. Adjuvanted influenza vaccines. Expert Rev Vaccines. 2013 Sep;12(9):1095-108.

67. Everett KH, Potter MA, Wheaton WD, Gleason SM, Brown ST, Lee BY. Geospatial analytics to evaluate point-of-dispensing sites for mass immunizations in Allegheny County, Pennsylvania. J Public Health Manag Pract. 2013 Sep-Oct;19 Suppl 2:S31-6.

68. Falup-Pecurariu O, Leibovitz E, Mercas A, Bleotu L, Zavarache C, Porat N, Dagan R, Greenberg D. Pneumococcal acute otitis media in infants and children in  central Romania, 2009-2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines. Int J Infect Dis. 2013 Sep;17(9):e702-6.

69. Fedson DS. Pneumococcal conjugate vaccination for older adults: Reply letter  to Hollingsworth et al. Hum Vaccin Immunother. 2013 Sep 12; 10(1). [Epub ahead of print].

70. Ferrini W, Aubert V, Balmer A, Munier FL, Abouzeid H. Anterior Uveitis and Cataract After Rubella Vaccination: A Case Report of a 12-Month-Old Girl. Pediatrics. 2013 Sep 2. [Epub ahead of print].

71. Fiebelkorn AP, Lawler J, Curns AT, Brandeburg C, Wallace GS. Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, orange county, new york, USA. Emerg Infect Dis. 2013 Sep; 19(9):1411-7.

72. Ford CA, Skiles MP, English A, Cai J, Agans RP, Stokley S, Markowitz L, Koumans EH. Minor Consent and Delivery of Adolescent Vaccines. J Adolesc Health.  2013 Sep 25. [Epub ahead of print].

73. Ford JA, Mahgoub H, Shankar AG. Vaccine acceptance: The UK perspective. Hum Vaccin Immunother. 2013 Sep 11;9(12). [Epub ahead of print] PubMed PMID:

74. Fry NK, Litt DJ, Duncan J, Vaghji L, Warrener L, Samuel D, Andrews N, Harnden A, Harrison TG. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay. J Med Microbiol. 2013 Sep;62(Pt 9):1281-9.

75. Fu C, Huang G, Cui M, Wang M. Post-marketing study on the safety of a meningococcal group A, C bivalent polysaccharide conjugate vaccine. Hum Vaccin Immunother. 2013 Sep 6;10(1). [Epub ahead of print].

76. Fujisawa T, Okumura Y, Shibuya Y, Kato G, Seishima M. Squamous cell carcinoma possibly originating from a granuloma following vaccination with Bacille Calmette-Guérin. Eur J Dermatol. 2013 Sep 24. [Epub ahead of print].

77. Gaczkowska A, Mertens B, Reckendrees B, Wortberg S, Pott E. [Knowledge, attitude, and practice concerning measles vaccination : Approaches for national vaccination education]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1270-8.

78. Ganry O, Bernin-Mereau AS, Gignon M, Merlin-Brochard J, Schmit JL. Human papillomavirus vaccines in Picardy, France: Coverage and correlation with socioeconomic factors. Rev Epidemiol Sante Publique. 2013 Sep 6. [Epub ahead of print].

79. Gargano LM, Thacker N, Choudhury P, Weiss PS, Russ RM, Pazol K, Arora M, Orenstein WA, Omer SB, Hughes JM. Pediatricians' perceptions of vaccine effectiveness and safety are significant predictors of vaccine administration in India. Int Health. 2013 Sep; 5(3):205-10.

80. Gatto M, Agmon-Levin N, Soriano A, Manna R, Maoz-Segal R, Kivity S, Doria A, Shoenfeld Y. Human papillomavirus vaccine and systemic lupus erythematosus. Clin  Rheumatol. 2013 Sep;32(9):1301-7.

81. Georges S, Lepoutre A, Dabernat H, Levy-Bruhl D. Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction. Epidemiol Infect. 2013 Sep;141(9):1787-96.

82. Gilbert SC. Advances in the development of universal influenza vaccines. Influenza Other Respi Viruses. 2013 Sep; 7(5):750-8.

83. Giri P, Basu S, Farrow D, Adisesh A. Cost-effectiveness analysis of MMR immunization in health care workers. Occup Med (Lond). 2013 Sep; 63(6):422-4.

84. Glanz JM, Wagner NM, Narwaney KJ, Shoup JA, McClure DL, McCormick EV, Daley  MF. A mixed methods study of parental vaccine decision making and parent-provider trust. Acad Pediatr. 2013 Sep-Oct; 13(5):481-8.

85. Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, Lee GM, Nelson JC, Naleway AL, Nordin JD, Lugg MM, Weintraub ES. Association Between Undervaccination With Diphtheria, Tetanus Toxoids, and Acellular Pertussis (DTaP) Vaccine and Risk of Pertussis Infection in Children 3 to 36 Months of Age. JAMA Pediatr. 2013 Sep 9. [Epub ahead of print].

86. Gleberzon B, Lameris M, Schmidt C, Ogrady J. On Vaccination & Chiropractic:  when ideology, history, perception, politics and jurisprudence collide. J Can Chiropr Assoc. 2013 Sep;57(3):205-13.

87. Goad JA, Taitel MS, Fensterheim LE, Cannon AE. Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med. 2013 Sep-Oct; 11(5):429-36.

88. Goldacker S, Gause AM, Warnatz K; Kommission Pharmakotherapie der DGRh. [Vaccination in adult patients with chronic inflammatory rheumatic diseases]. Z Rheumatol. 2013 Sep;72(7):690-704.

89. Gopal R, Rangel-Moreno J, Slight S, Lin Y, Nawar HF, Fallert Junecko BA, Reinhart TA, Kolls J, Randall TD, Connell TD, Khader SA. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol. 2013 Sep;6(5):972-84.

90. Gorczyca D, Schwirten U. Sensorimotor polyneuropathy after hexavalent vaccination. Scand J Infect Dis. 2013 Sep 20. [Epub ahead of print].

91. Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age. Vaccine. 2013 Sep 19. [Epub ahead of print].

92. Gotuzzo E, Yactayo S, Córdova E. Efficacy and duration of immunity after yellow Fever vaccination: systematic review on the need for a booster every 10 years. Am J Trop Med Hyg. 2013 Sep;89(3):434-44.

93. Griffin MR. Influenza Vaccination of Health Care Workers: Making the Grade for Action. Clin Infect Dis. 2013 Sep 17. [Epub ahead of print].

94. Guthridge JM, Cogman A, Merrill JT, Macwana S, Bean KM, Powe T, Roberts V, James JA, Chakravarty EF. Herpes Zoster Vaccination in SLE: A Pilot Study of Immunogenicity. J Rheumatol. 2013 Sep 15. [Epub ahead of print].

95. Hadisoemarto PF, Castro MC. Public Acceptance and Willingness-to-Pay for a Future Dengue Vaccine: A Community-Based Survey in Bandung, Indonesia. PLoS Negl  Trop Dis. 2013 Sep 19;7(9):e2427.

96. Hagihara Y, Ohfuji S, Watanabe K, Yamagami H, Fukushima W, Maeda K, Kamata N, Sogawa M, Shiba M, Tanigawa T, Tominaga K, Watanabe T, Fujiwara Y, Hirota Y, Arakawa T. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. J Crohns Colitis. 2013 Sep 4. [Epub ahead of print].

97. Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz  MM, Paul P, Rajgopal J, Welling JS, Leonard J, Claypool EG, Weng YT, Chen SI, Lee BY. Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks. J Public Health Manag Pract. 2013 Sep-Oct;19 Suppl 2:S65-7.

98. Halstead SB. Identifying protective dengue vaccines: Guide to mastering an empirical process. Vaccine. 2013 Sep 23;31(41):4501-7.

99. Hannoun C. The evolving history of influenza viruses and influenza vaccines. Expert Rev Vaccines. 2013 Sep;12(9):1085-94.

100. Hansen L, Pieters S, Montenez JP, Daoussi R, Vander Heyden Y, Vervaet C, Remon JP, De Beer T. Near-infrared spectroscopic evaluation of lyophilized viral  vaccine formulations. Biotechnol Prog. 2013 Sep 7. [Epub  ahead of print].

101. Hata A, Inoue F, Yamasaki M, Fujikawa J, Kawasaki Y, Hamamoto Y, Honjo S, Moriishi E, Mori Y, Koshiyama H. Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus. J Infect.  2013 Sep; 67(3):215-9.

102. Hechter RC, Tartof SY, Jacobsen SJ, Smith N, Tseng HF. Trends and disparity  in zoster vaccine uptake in a managed care population. Vaccine. 2013 Sep 23;31(41):4564-8.

103. Hechter RC, Chao C, Sy LS, Ackerson BK, Slezak JM, Sidell MA, Jacobsen SJ. Quadrivalent human papillomavirus vaccine uptake in adolescent boys and maternal  utilization of preventive care and history of sexually transmitted infections. Am J Public Health. 2013 Sep; 103(9):e63-8.

104. Heier MS, Gautvik KM, Wannag E, Bronder KH, Midtlyng E, Kamaleri Y, Storsaeter J. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 2013 Sep;14(9):867-71.

105. Herbinger KH, von Sonnenburg F, Nothdurft HD, Perona P, Borkowski A, Fragapane E, Nicolay U, Clemens R. A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59(®): Adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy  adults. Hum Vaccin Immunother. 2013 Sep 20; 10(1). [Epub ahead of print].

106. Hofman R, van Empelen P, Richardus JH, de Kok IM, de Koning HJ, van Ballegooijen M, Korfage IJ. Predictors of HPV vaccination uptake: a longitudinal study among parents. Health Educ Res. 2013 Sep 16. [Epub ahead of print].

107. Holder NA, Katzenellenbogen R, Middleman AB. Human papillomavirus vaccines:  factors that affect vaccine knowledge and delivery. J Adolesc Health. 2013 Sep;53(3):423-5.

108. Hong X, Wei L, Wu F, Wu Z, Chen L, Liu Z, Yuan W. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine. Drug Des Devel Ther. 2013 Sep 4;7:945-952.

109. Horácio AN, Diamantino-Miranda J, Aguiar SI, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections. The majority of adult pneumococcal invasive infections in portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5. PLoS One. 2013 Sep 16; 8(9):e73704.

110. Howie SR, Oluwalana C, Secka O, Scott S, Ideh RC, Ebruke BE, Balloch A,Sambou S, Erskine J, Lowe Y, Corrah T, Adegbola RA. The Effectiveness of Conjugate Haemophilus influenzae type b (Hib) Vaccine in The Gambia 14 years after Introduction. Clin Infect Dis. 2013 Sep 17. [Epub ahead of print].

111. Hsieh YC, Fang-Tzywu, Hsiung CA, Wu HS, Chang KY, Huang YC. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine. Vaccine. 2013 Sep 24. [Epub ahead of print].

112. Hung WT, Lee SS, Sy CL, Wu KS, Chen JK, Tsai HC, Chen YS. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country. J Microbiol Immunol Infect. 2013 Sep 23. [Epub ahead of print].

113. Ibrahim N, Wicklund A, Jamin A, Wiebe MS. Barrier to autointegration factor  (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase. Virology. 2013 Sep; 444(1-2):363-73.

114. Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep. 2013 Sep 20;62(RR-07):1-43.

115. Ito D, Hasegawa T, Miura K, Yamasaki T, Arumugam TU, Thongkukiatkul A, Takeo S, Takashima E, Sattabongkot J, Han ET, Long CA, Torii M, Tsuboi T. RALP1 is a rhoptry-neck erythrocyte-binding protein of Plasmodium falciparum merozoite and a potential blood-stage vaccine candidate antigen. Infect Immun. 2013 Sep 3. [Epub  ahead of print].

116. James EA, Lafond RE, Gates TJ, Mai DT, Malhotra U, Kwok WW. Yellow Fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and non-structural proteins. J Virol. 2013 Sep 18. [Epub ahead of print].

117. Jiménez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, Castilla J, Pérez E, Gallardo V, Rodriguez C, Vega T, Quiñones C, Martínez E,  Vanrell JM, Giménez J, Castrillejo D, Serrano MD, Ramos JM, Larrauri A. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011--2012 season in Spain, among population targeted for vaccination. BMC Infect Dis. 2013 Sep 22;13(1):441. [Epub ahead of print].

118. Jones C, Lee CK, Ahn C, Shin J, Knezevic I. Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012. Vaccine. 2013 Sep 23;31(41):4466-9.

119. Jones Cooper SN, Walton-Moss B. Using reminder/recall systems to improve influenza immunization rates in children with asthma. J Pediatr Health Care. 2013 Sep-Oct;27(5):327-33.

120. Kaczmarek MC, Duong UT, Ware RS, Lambert SB, Kelly HA. The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged ≥6 months to <36 months: A comparison of published and unpublished studies. Vaccine. 2013 Sep 19. [Epub ahead of print].

121. Kavanagh K, Robertson C, McMenamin J. Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method-Experience across the 2010/11 season. Vaccine. 2013 Sep 23; 31(41):4556-63.

122. Kelly HA, Sullivan SG, Grant KA, Fielding JE. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. Influenza Other Respi Viruses. 2013 Sep; 7(5):729-37.

123. Keogh K. Trusts warned to boost flu vaccine uptake, or lose share of £500m.  Nurs Stand. 2013 Sep 25; 28(4):14-5.

124. Kernéis S, Launay O, Ancelle T, Iordache L, Naneix-Laroche V, Méchaï F, Fehr T, Leroy JP, Issartel B, Dunand J, van der Vliet D, Wyplosz B, Consigny PH, Hanslik T. Safety and Immunogenicity of Yellow Fever 17D Vaccine in Adults Receiving Systemic Corticosteroid Therapy: An Observational Cohort Study. Arthritis Care Res (Hoboken). 2013 Sep; 65(9):1522-8.

125. Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin JD; Vaccine Safety Datalink Team. Inactivated influenza vaccine during pregnancy and  risks for adverse obstetric events. Obstet Gynecol. 2013 Sep;122(3):659-67.

126. Khawaja S, Cardellino A, Mast TC. Hospital-Based Surveillance and Analysis of Genotype Variation in Nicaragua after the Introduction of the Pentavalent Rotavirus Vaccine. Pediatr Infect Dis J. 2013 Sep 13. [Epub ahead of print].

127. Kilgus CD, Redmon G. Enabling Reimbursement to Health Departments for Immunization Services. J Public Health Manag Pract. 2013 Sep 10. [Epub ahead of print].

128. Kiraly N, Benn CS, Biering-Sørensen S, Rodrigues A, Jensen KJ, Ravn H, Allen KJ, Aaby P. Vitamin A supplementation and BCG vaccination at birth may affect atopy in childhood: long-term follow-up of a randomized controlled trial. Allergy. 2013 Sep;68(9):1168-76.

129. Klein NP, Ensor K, Jouve S, Northington R, Moscariello M, McGovern PC. Long-term Immune Responses to Pneumococcal Conjugate Vaccines in Children Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine. Pediatr Infect Dis J. 2013 Sep; 32(9):990-7.

130. Koch J, Takla A. [Effects of the MMR vaccination on the epidemiology of mumps in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1305-12.

131. Krajden M, Cook D, Yu A, Chow R, Su Q, Mei W, McNeil S, Money D, Dionne M, Palefsky J, Karunakaran K, Kollmann T, Ogilvie G, Petric M, Dobson S. Assessment  of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial. Vaccine. 2013 Sep 18. [Epub ahead of print].

132. Krishna V, Ramanan PV, Rajendran P. Enteric Fever in Children Below 2 y - Need for an Effective Conjugate Vaccine? Indian J Pediatr. 2013 Sep 14. [Epub ahead of print].

133. Kung YH, Chiu NC, Lee KS, Chang L, Huang DT, Huang FY, Hsieh YC, Huang LM, Chi H. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children. J Microbiol Immunol Infect. 2013  Sep 27. [Epub ahead of print].

134. Kunze U, Böhm G, Groman E. Influenza vaccination in Austria from 1982 to 2011: A country resistant to influenza prevention and control. Vaccine. 2013 Sep  5. [Epub ahead of print].

135. Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, Stukel TA, Crowcroft NS, McGeer AJ, Zinman L, Deeks SL. Risk of Guillain-Barré syndromeafter seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis. 2013 Sep;13(9):769-76.

136. Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter AL, Olsha R, Turner R, Rosella LC, Crowcroft NS. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis. 2013 Sep;57(6):820-7.

137. Lam SK. Challenges in reducing dengue burden; diagnostics, control measures  and vaccines. Expert Rev Vaccines. 2013 Sep;12(9):995-1010.

138. Lambert SB, Chuk LM, Nissen MD, Nolan TM, McVernon J, Booy R, Heron L, Richmond PC, Walls T, Marshall HS, Reynolds GJ, Hartel GF, Hu W, Lai MH. Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents. Influenza Other Respi Viruses. 2013 Sep;7(5):676-85.

139. Lameris M, Schmidt C, Gleberzon B, Ogrady J. Attitudes toward vaccination: A cross-sectional survey of students at the Canadian Memorial Chiropractic College. J Can Chiropr Assoc. 2013 Sep;57(3):214-20.

140. Lang PO, Govind S, Bokum AT, Kenny N, Matas E, Pitts D, Aspinall R. Immune Senescence And Vaccination In The Elderly. Curr Top Med Chem. 2013 Sep 25. [Epub  ahead of print].

141. Lantos JD. Why money will not cure under-immunization. Hum Vaccin Immunother. 2013 Sep 16;9(12). [Epub ahead of print].

142. Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwarz TF, Watanveerade V, Wenzel JJ, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A,  Gillard P, Vaughn DW. Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomized trials. BMC Infect Dis. 2013 Sep 16; 13(1):435. [Epub ahead of print].

143. Levin MJ, Schmader KE, Gnann JW, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J. Varicella-Zoster Virus-Specific Antibody Responses in 50-59-Year-Old Recipients of Zoster Vaccine. J Infect Dis. 2013 Sep 4. [Epub ahead of print].

144. Li RC, Huang T, Li Y, Luo D, Tao J, Fu B, Si G, Nong Y, Mo Z, Liao X, Luan I, Tang H, Rathi N, Karkada N, Htay Han H. Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China. Hum Vaccin Immunother. 2013 Sep 6; 10(1). [Epub ahead of print].

145. Liddon N, Michael SL, Dittus P, Markowitz LE. Maternal Underestimation of Child's Sexual Experience: Suggested Implications for HPV Vaccine Uptake at Recommended Ages. J Adolesc Health. 2013 Sep 12. [Epub ahead of print].

146. Liese JG, Cohen C, Rack A, Pirzer K, Eber S, Blum M, Greenberg M, Streng A.  The Effectiveness of Varicella Vaccination in Children in Germany: A Case-control Study. Pediatr Infect Dis J. 2013 Sep;32(9):998-1004.

147. Lindley MC, Lorick SA, Geevarughese A, Lee SJ, Makvandi M, Miller BL, Nace DA, Smith C, Ahmed F. Evaluating a standardized measure of healthcare personnel influenza vaccination. Am J Prev Med. 2013 Sep;45(3):297-303.

148. Liu Y, Yin Y, Wang L, Zhang W, Chen X, Yang X, Xu J, Ma G. Engineering biomaterial-associated complement activation to improve vaccine efficacy. Biomacromolecules. 2013 Sep 9; 14(9):3321-8.

149. Louik C, Ahrens K, Kerr S, Pyo J, Chambers C, Jones KL, Schatz M, Mitchell AA. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: Exposure prevalence, preterm delivery, and specific birth defects. Vaccine. 2013 Sep 7. [Epub ahead of print].

150. Lu PJ, Singleton JA, Euler GL, Williams WW, Bridges CB. Seasonal Influenza Vaccination Coverage Among Adult Populations in the United States, 2005-2011. Am  J Epidemiol. 2013 Sep 5. [Epub ahead of print].

151. Luangkesorn KL, Ghiasabadi F, Chhatwal J. A sequential experimental design method to evaluate a combination of school closure and vaccination policies to control an H1N1-like pandemic. J Public Health Manag Pract. 2013 Sep-Oct; 19 Suppl 2:S37-41.

152. Luchs A, Cilli A, Morillo SG, de Cassia Compagnoli Carmona R, do Carmo Sampaio Tavares Timenetsky M. Rotavirus in adults, Brazil, 2004-2011: G2P[4] dominance and potential impact on vaccination. Braz J Infect Dis. 2013 Sep 25. [Epub ahead of print].

153. Lucidarme J, Gilchrist S, Newbold LS, Gray SJ, Kaczmarski EB, Richardson L,  Bennett JS, Maiden MC, Findlow J, Borrow R. Genetic Distribution of Noncapsular Meningococcal Group B Vaccine Antigens in Neisseria lactamica. Clin Vaccine Immunol. 2013 Sep; 20(9):1360-9.

154. Lugnér AK, van der Maas N, van Boven M, Mooi FR, de Melker HE. Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: Comparing neonatal, maternal, and cocooning vaccination strategies. Vaccine. 2013 Sep 26. [Epub ahead of print].

155. Luthy KE, Beckstrand RL, Pulsipher A. Evaluation of methods to relieve parental perceptions of vaccine-associated pain and anxiety in children: a pilot  study. J Pediatr Health Care. 2013 Sep-Oct; 27(5):351-8.

156. Lyons AC. Morality, Responsibility and Risk: The Importance of Alternative Perspectives in Vaccination Research. Int J Behav Med. 2013 Sep 26. [Epub ahead of print].

157. Machicado JD, Bhagya-Rao B, Davogustto G, McKelvy BJ. Acute Disseminated Encephalomyelitis following Seasonal Influenza Vaccination in an Elderly Patient. Clin Vaccine Immunol. 2013 Sep; 20(9):1485-6.

158. Macken WL, Macken HC, Callanan I, Butler MW. Not written, not done: are we identifying elderly at-risk patients for pneumococcal vaccination? Ir J Med Sci.  2013 Sep;182(3):523-7.

159. Mahalakshmi N, Aparnaa R, Ansel Vishal L, Kaliraj P. Molecular characterization and evaluation of Onchocerca volvulus-secreted larval acidic protein 1 (SLAP1) as a putative vaccine candidate on endemic population of lymphatic filariasis. Parasitol Res. 2013 Sep; 112(9):3203-11.

160. Maher L, Hope K, Torvaldsen S, Lawrence G, Dawson A, Wiley K, Thomson D, Hayen A, Conaty S. Influenza vaccination during pregnancy: Coverage rates and influencing factors in two urban districts in Sydney. Vaccine. 2013 Sep 25. [Epub ahead of print].

161. Mahla RS, Reddy MC, Prasad DV, Kumar H. Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology. Front Immunol. 2013 Sep 2; 4:248.

162. Majumder PP, Sarkar-Roy N, Staats H, Ramamurthy T, Maiti S, Chowdhury G, Whisnant CC, Narayanasamy K, Wagener DK. Genomic correlates of variability in immune response to an oral cholera vaccine. Eur J Hum Genet. 2013 Sep;21(9):1000-6.

163. Maltezou HC, Fotiou A, Antonakopoulos N, Kallogriopoulou C, Katerelos P, Dimopoulou A, Tsoutsa V, Siahanidou T, Papagaroufalis C, Kostis E, Papantoniou N, Antsaklis A, Theodoridou M. Impact of Post-Partum Influenza Vaccination of Mothers and Household Contacts in Preventing Febrile Episodes, Influenza-Like Illness, Health-Care Seeking, and Administration of Antibiotics in Young Infants  during the 2012-2013 Influenza Season. Clin Infect Dis. 2013 Sep 17. [Epub ahead  of print].

164. Maraskovsky E. Response to letter by Paul Effler and Heath Kelly to Vaccine. Vaccine. 2013 Sep 11. [Epub ahead of print].

165. Maruri-Avidal L, Weisberg AS, Moss B. Direct Formation of Vaccinia Viral Membranes from the Endoplasmic Reticulum in the Absence of the Newly Characterized L2-Interacting A30.5 Protein. J Virol. 2013 Sep 11. [Epub ahead of print].

166. Matheny Antommaria AH. An ethical analysis of mandatory influenza vaccination of health care personnel: implementing fairly and balancing benefits  and burdens. Am J Bioeth. 2013 Sep;13(9):30-7.

167. McKeage K. Inactivated Quadrivalent Split-Virus Seasonal Influenza Vaccine (Fluarix(®) Quadrivalent): A Review of Its Use in the Prevention of Disease Caused by Influenza A and B. Drugs. 2013 Sep 11. [Epub ahead of print].

 168. Meharry PM, Cusson RM, Stiller R, Vázquez M. Maternal Influenza Vaccination: Evaluation of a Patient-Centered Pamphlet Designed to Increase Uptake in Pregnancy. Matern Child Health J. 2013 Sep 22. [Epub ahead of print].

169. Mekalanos JJ. Vaccine economics: what price human life? Sci Transl Med. 2013 Sep 25; 5(204):204ed16.

170. Mentzer D, Meyer H, Keller-Stanislawski B. [Safety and tolerability of monovalent measles and combined measles, mumps, rubella, and varicella vaccines]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1253-9.

171. Mergler MJ, Omer SB, Pan WK, Navar-Boggan AM, Orenstein W, Marcuse EK, Taylor J, Dehart MP, Carter TC, Damico A, Halsey N, Salmon DA. Association of vaccine-related attitudes and beliefs between parents and health care providers.  Vaccine. 2013 Sep 23; 31(41):4591-5.

172. Merry C, Fitzgerald RJ. Regional lymphadenitis following BCG vaccination. Pediatr Surg Int. 1996 Apr;11(4):269-71.

173. Merten S, Schaetti C, Manianga C, Lapika B, Hutubessy R, Chaignat CL, Weiss  M. Sociocultural determinants of anticipated vaccine acceptance for acute watery  diarrhea in early childhood in Katanga province, democratic republic of congo. Am J Trop Med Hyg. 2013 Sep;89(3):419-25.

174. Mo AX, Augustine AD. NIAID meeting report: Improving malaria vaccine strategies through the application of immunological principles. Vaccine. 2013 Sep 20. [Epub ahead of print].

175. Moniz MH, Vitek WS, Akers A, Meyn LA, Beigi RH. Perceptions and acceptance of immunization during pregnancy. J Reprod Med. 2013 Sep-Oct; 58(9-10):383-8.

176. Mori M, Hasegawa J, Showa S, Matsushima A, Ohnishi H, Yoto Y, Tsutsumi H. Effectiveness of influenza vaccine in children in day-care centers of Sapporo. Pediatr Int. 2013 Sep 11. [Epub ahead of print].

177. Moss JL, Gilkey MB, Griffith T, Bowling JM, Dayton AM, Grimshaw AH, Quinn B, Brewer NT. Organizational correlates of adolescent immunization: Findings of a state-wide study of primary care clinics in North Carolina. Vaccine. 2013 Sep 13;31(40):4436-41.

178. Moyer CA, Tadesse L, Fisseha S. The relationship between facility delivery and infant immunization in Ethiopia. Int J Gynaecol Obstet. 2013 Sep 3. [Epub ahead of print].

179. Munoz FM, Sheffield JS, Beigi RH, Read JS, Swamy GK, Jevaji I, Rasmussen SA, Edwards KM, Fortner KB, Patel SM, Spong CY, Ault K, Heine RP, Nesin M. Research on vaccines during pregnancy: Protocol design and assessment of safety. Vaccine.  2013 Sep 13;31(40):4274-9.

180. Murdaca G, Orsi A, Spanò F, Puppo F, Durando P, Icardi G, Ansaldi F. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: Current views upon safety and immunogenicity. Autoimmun Rev. 2013  Sep 14. [Epub ahead of print].

181. Nazi I, Kelton JG, Larché M, Snider DP, Heddle NM, Crowther MA, Cook RJ, Tinmouth AT, Mangel J, Arnold DM. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 2013 Sep 12;122(11):1946-53.

182. Negishi H, Mori M, Mori H, Yamori Y. Supplementation of Elderly Japanese Men and Women with Fucoidan from Seaweed Increases Immune Responses to Seasonal Influenza Vaccination. J Nutr. 2013 Sep 4. [Epub ahead of print].

183. Njuguna H, Ahmed J, Oria PA, Arunga G, Williamson J, Kosgey A, Muthoka P, Mott JA, Breiman RF, Katz MA. Uptake and effectiveness of monovalent influenza A  (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010. Vaccine.  2013 Sep 23; 31(41):4662-7.

184. Norman BA, Nourollahi S, Chen SI, Brown ST, Claypool EG, Connor DL, Schmitz  MM, Rajgopal J, Wateska AR, Lee BY. A passive cold storage device economic model  to evaluate selected immunization location scenarios. Vaccine. 2013 Sep 7. [Epub ahead of print].

185. Ntumngia FB, Schloegel J, McHenry AM, Barnes SJ, George MT, Kennedy S, Adams JH. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II. Vaccine. 2013 Sep 13;31(40):4382-8.

186. O Grady KA, Grimwood K, Cripps A, Mulholland EK, Morris P, Torzillo PJ, Wood N, Smith-Vaughan H, Revell A, Wilson A, Van Asperen P, Richmond P, Thornton R, Rablin S, Chang AB. Does a 10-valent pneumococcal-Haemophilus influenzae protein  D conjugate vaccine prevent respiratory exacerbations in children with recurrent  protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials. 2013 Sep 5;14(1):282. [Epub ahead of print].

187. O'Connor D, Pollard AJ. Characterizing vaccine responses using host genomic  and transcriptomic analysis. Clin Infect Dis. 2013 Sep;57(6):860-9.

188. Oftadeh S, Gidding HF, Gilbert GL. Laboratory surveillance of invasive pneumococcal disease in New South Wales, Australia, before and after introduction of 7-valent conjugate vaccine: reduced disease, but not antibiotic resistance rates. Epidemiol Infect. 2013 Sep; 141(9):1797-806.

189. Opel DJ, Taylor JA, Zhou C, Catz S, Myaing M, Mangione-Smith R. The Relationship Between Parent Attitudes About Childhood Vaccines Survey Scores and  Future Child Immunization Status: A Validation Study. JAMA Pediatr. 2013 Sep 23.  [Epub ahead of print].

190. Orr N, Elliott MN, Burkhart Q, Haviland A, Weinick RM. Racial/Ethnic differences in medicare experiences and immunization: the role of disease burden. Med Care. 2013 Sep; 51(9):823-31.

191. Otsuka SH, Tayal NH, Porter K, Embi PJ, Beatty SJ. Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record. Am J Med. 2013 Sep;126(9):832.e1-6.

192. Ozdemir H, Ciftçi E, Durmaz R, Güriz H, Aysev AD, Karbuz A, Gökdemir R, Acar B, Nar Ötgün S, Ertek M, Köse SK, Ince E. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule. Eur J Pediatr. 2013 Sep 18. [Epub ahead of print].

193. Panozzo CA, Becker-Dreps S, Pate V, Jonsson Funk M, Stürmer T, Weber DJ, Brookhart MA. Patterns of Rotavirus Vaccine Uptake and Use in Privately-Insured US Infants, 2006-2010. PLoS One. 2013 Sep 16;8(9):e73825.

194. Patel AR, Zietlow J, Jacobson RM, Poland GA, Juhn YJ. Asthma and the immune  response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study. Prim Care Respir J. 2013 Sep;22(3):278-83.

195. Patel D, Simons H. Yellow fever vaccination: Is one dose always enough? Travel Med Infect Dis. 2013 Sep 5. [Epub ahead of print].

196. Pedrosa AF, Morais P, Nogueira A, Pardal J, Azevedo F. Sweet's syndrome triggered by pneumococcal vaccination. Cutan Ocul Toxicol. 2013 Sep;32(3):260-1. 

197. Poethko-Müller C, Mankertz A. [Vaccination coverage against measles and sero-epidemiology of measles-specific IgG antibodies in German children and adolescents]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1243-52.

198. Poland GA. Visual vaccinology - the importance of visual communication. Vaccine. 2013 Sep 23; 31(41):4465.

199. Principi N, Esposito S. Adolescents and vaccines in the western world. Vaccine. 2013 Sep 9. [Epub ahead of print].

200. Pépin S, Donazzolo Y, Jambrecina A, Salamand C, Saville M. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults. Vaccine. 2013 Sep 6. [Epub ahead of print].

201. Quantin C, Benzenine E, Velten M, Huet F, Farrington CP, Tubert-Bitter P. Self-Controlled Case Series and Misclassification Bias Induced by Case Selection  from Administrative Hospital Databases: Application to Febrile Convulsions in Pediatric Vaccine Pharmacoepidemiology. Am J Epidemiol. 2013 Sep 27. [Epub ahead  of print].

202. Quintana LF, Serra N, De Molina-Llauradó P, Blasco M, Martinez M, Campos B,  Bayas JM, Pumarola T, Campistol JM. Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine. Influenza Other Respi Viruses. 2013 Sep; 7(5):809-814.

203. Radtke MA, Rustenbach SJ, Reusch M, Strömer K, Augustin M. Influenza vaccination rate among patients with moderate to severe psoriasis. J Dtsch Dermatol Ges. 2013 Sep; 11(9):837-44.

204. Rafferty E, Duclos P, Yactayo S, Schuster M. Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: Systematic review. Vaccine. 2013 Sep 27. [Epub ahead of print].

205. Raina Macintyre C, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, Gao Z, Katelaris AL, Siu HW, Lo V, Lindley R, Dwyer DE. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 2013 Sep 25. [Epub ahead of print].

206. Ren J, Shen J, Chen W, Shen H, Gu S, Lu H. [Meta analysis on the immunogenicity of domestic influenza virus vaccines]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Sep; 29(9):981-5. Chinese.

207. Riccio EK, Totino PR, Pratt-Riccio LR, Ennes-Vidal V, Soares IS, Rodrigues MM, de Souza JM, Daniel-Ribeiro CT, Ferreira-da-Cruz MD. Cellular and humoral immune responses against the Plasmodium vivax MSP-119 malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil. Malar J. 2013 Sep 16; 12(1):326. [Epub ahead of print].

208. Rivera R, Forney K, Castro MR, Rebolledo PA, Mamani N, Patzi M, Halkyer P, Leon JS, Iñiguez V. Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007-2008. Int J Infect Dis. 2013 Sep; 17(9):e762-7.

209. Rodrigo C, Bewick T, Sheppard C, Greenwood S, Macgregor V, Trotter C, Slack  M, George R, Lim WS. Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status. Thorax. 2013 Sep 18. [Epub ahead of print].

210. Rohner GB, Meier S, Bel M, Combescure C, Othenin-Girard V, Swali RA, de Tejada BM, Siegrist CA. Influenza Vaccination Given at Least 2 Weeks before Delivery to Pregnant Women Facilitates Transmission of Seroprotective Influenza-Specific Antibodies to the Newborn. Pediatr Infect Dis J. 2013 Sep 20.  [Epub ahead of print].

211. Roxo-Junior P, Silva J, Andrea M, Oliveira L, Ramalho F, Bezerra T, Nunes AA. A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of severe primary immunodeficiency. Ital J Pediatr. 2013  Sep 10;39(1):54. [Epub ahead of print].

212. Ruiz-Aragón J, Peláez SM, Molina-Linde JM, Grande-Tejada AM. Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: A meta-analysis. Vaccine. 2013 Sep 19. [Epub ahead of print].

213. Régnier SA, Huels J. Drug versus vaccine investment: a modelled comparison of economic incentives. Cost Eff Resour Alloc. 2013 Sep 8; 11(1):23. [Epub ahead of print].

214. Régnier SA. Respiratory syncytial virus immunization program for the United  States: Impact of performance determinants of a theoretical vaccine. Vaccine. 2013 Sep 13; 31(40):4347-54.

215. Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 2013 Sep 13;31(40):4293-304.

216. Sahastrabuddhe S, Carbis R, Wierzba TF, Leon Ochiai R. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development. Expert  Rev Vaccines. 2013 Sep; 12(9):1021-31.

217. Saito MM, Imoto S, Yamaguchi R, Tsubokura M, Kami M, Nakada H, Sato H, Miyano S, Higuchi T. Enhancement of Collective Immunity in Tokyo Metropolitan Area by Selective Vaccination against an Emerging Influenza Pandemic. PLoS One. 2013 Sep 18;8(9):e72866.

218. Sallam MA, Attia EA, Soliman MS. Assessment of serum level of interleukin-1β and interleukin-12 in leprosy: impact of previous Bacillus Calmitte Guerin vaccination. Arch Dermatol Res. 2013 Sep 11. [Epub ahead of print].

219. Scherpenisse M, Schepp RM, Mollers M, Meijer CJ, Berbers GA, van der Klis FR. Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses. PLoS One. 2013 Sep 18;8(9):e74797

220. Schuler CL, Hanley CJ, Coyne-Beasley T. Misconception: Human Papillomavirus  Vaccine and Infertility. Clin Pediatr (Phila). 2013 Sep 26. [Epub ahead of print].

221. Schulz C, Hammerschmidt S. Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates. Expert Rev Vaccines. 2013 Sep; 12(9):1061-75.

222. Schwartz JL. "Model" patients and the consequences of provider responses to  vaccine hesitancy. Hum Vaccin Immunother. 2013 Sep 9; 9(12). [Epub ahead of print].

223. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL, Sedegah M, Sutamihardja A, Fahle GA, Lyke KE, Laurens  MB, Roederer M, Tewari K, Epstein JE, Sim BK, Ledgerwood JE, Graham BS, Hoffman SL; VRC 312 Study Team. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013 Sep 20; 341(6152):1359-65.

224. Sheffield JS, Munoz FM, Beigi RH, Rasmussen SA, Edwards KM, Read JS, Heine RP, Ault KA, Swamy GK, Jevaji I, Spong CY, Fortner KB, Patel SM, Nesin M. Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments. Vaccine. 2013 Sep 13; 31(40):4264-73.

225. Shen CF, Wang SM, Lee KH, Ho TS, Liu CC. Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan. J Formos Med Assoc. 2013 Sep; 112(9):561-568.

226. Short MB, Middleman AB. Focusing on flu: Adolescents' perspectives on school-located immunization programs for influenza vaccine. Hum Vaccin Immunother. 2013 Sep 9; 10(1). [Epub ahead of print].

227. Siedler A, Hecht J, Rieck T, Tolksdorf K, Hengel H. [Varicella vaccination in Germany : A provisional appraisal in the context of MMR vaccination]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1313-20.

228. Silva CA, Aikawa NE, Bonfa E. Vaccinations in juvenile chronic inflammatory  diseases: an update. Nat Rev Rheumatol. 2013 Sep;9(9):532-43.

229. Silvaggio JL, Van Otterloo J, Curran EA, Whitney EA, Weiss PS, Seib K, Omer  SB. Vaccine Providers' Perspectives on Impact, Challenges, and Response during the California 2010 Pertussis Outbreak. Hum Vaccin Immunother. 2013 Sep 17; 10(1). [Epub ahead of print].

230. Singh PK. Trends in Child Immunization across Geographical Regions in India: Focus on Urban-Rural and Gender Differentials. PLoS One. 2013 Sep 4; 8(9):e73102. 

231. Smith GL, Benfield CT, Maluquer de Motes C, Mazzon M, Ember SW, Ferguson BJ, Sumner RP. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol. 2013 Sep 2. [Epub ahead of print].

232. Snape MD, Saroey P, John TM, Robinson H, Kelly S, Gossger N, Yu LM, Wang H,  Toneatto D, Dull PM, Pollard AJ. Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose. CMAJ. 2013 Sep 23. [Epub ahead of print].

233. Song G. Understanding Public Perceptions of Benefits and Risks of Childhood  Vaccinations in the United States. Risk Anal. 2013 Sep 13. [Epub ahead of print].

234. Song JY, Cheong HJ, Noh JY, Seo YB, Choi WS, Cho GJ, Hwang TG, Kim WJ. Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine. J Med Virol. 2013 Sep;85(9):1591-7.

235. Spier RE, Poland GA. What is excellent science and how does it relate to what we publish in vaccine? Vaccine. 2013 Sep 5. [Epub ahead of print].

236. Spijkerman J, Veenhoven RH, Wijmenga-Monsuur AJ, Elberse KE, van Gageldonk PG, Knol MJ, de Melker HE, Sanders EA, Schouls LM, Berbers GA. Immunogenicity of  13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial. JAMA. 2013 Sep 4;310(9):930-7.

237. Stephens P. Our national obsession with flu vaccine. Am J Nurs. 2013 Sep;113(9):11.

238. Strohfus PK, Collins T, Phillips V, Remington R. Health care providers' knowledge assessment of measles, mumps, and rubella vaccine. Appl Nurs Res. 2013  Sep 24. [Epub ahead of print]

239. Stumpf KA, Thompson T, Sánchez PJ. Rotavirus Vaccination of Very Low Birth Weight Infants at Discharge From the NICU. Pediatrics. 2013 Sep; 132(3):e662-5.

240. Sullivan SG, Tay EL, Kelly H. Variable definitions of the influenza season and their impact on vaccine effectiveness estimates. Vaccine. 2013 Sep 13; 31(40):4280-3.

241. Thompson MG, Sokolow LZ, Almendares O, Openo K, Farley MM, Meek J, Ray J, Kirley PD, Reingold A, Aragon D, Hancock E, Baumbach J, Schaffner W, Lynfield R,  Ryan P, Monroe M, Cheng PY, Fry AM, Shay DK. Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction-Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites. Clin Infect Dis. 2013 Sep 6. [Epub ahead of print].

242. Tiblad E, Westgren M, Pasupathy D, Karlsson A, Wikman AT. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies. Acta Obstet Gynecol Scand. 2013 Sep;92(9):1079-85.

243. Tin Tin Htar M, Madhava H, Balmer P, Christopoulou D, Menegas D, Bonnet E. A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent)  on Pneumococcal Meningitis. Adv Ther. 2013 Aug; 30(8):748-62.

244. Togashi T, Yamaji M, Thompson A, Giardina PC, Aizawa M, Patterson S, Gruber  WC, Scott DA; 3003 Study Group. Immunogenicity and Safety of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Japan. Pediatr Infect Dis J. 2013 Sep; 32(9):984-9.

245. Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res. 2013 Sep 26; 13(1):359. [Epub ahead of print].

246. van der Maas NA, Mooi FR, de Greeff SC, Berbers GA, Spaendonck MA, de Melker HE. Pertussis in the Netherlands, is the current vaccination strategy sufficient  to reduce disease burden in young infants? Vaccine. 2013 Sep 23; 31(41):4541-7.

247. van der Velden MV, Fritz R, Pöllabauer EM, Portsmouth D, Howard MK, Kreil TR, Dvorak T, Fritsch S, Vesikari T, Diez-Domingo J, Richmond P, Lee BW, Kistner  O, Ehrlich HJ, Barrett PN, Aichinger G. Safety and Immunogenicity of a Vero Cell  Culture-Derived Whole-Virus H5N1 Influenza Vaccine in a Pediatric Population. J Infect Dis. 2013 Sep 16. [Epub ahead of print].

248. Verdijk P, Rots NY, van Oijen MG, Oberste MS, Boog CJ, Okayasu H, Sutter RW, Bakker WA. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: A phase I trial in healthy adults. Vaccine. 2013 Sep 21. [Epub ahead of print].

249. Vesikari T, Uhari M, Renko M, Hemming M, Salminen M, Torcel-Pagnon L, Bricout H, Simondon F. Impact and Effectiveness of Rotateq® Vaccine Based on Three Years of Surveillance Following Introduction of a Rotavirus Immunization Program in Finland. Pediatr Infect Dis J. 2013 Sep 18. [Epub ahead of print].

250. von Seidlein L, Bejon P. Malaria vaccines: past, present and future. Arch Dis Child. 2013 Sep 23. [Epub ahead of print].

251. Wald A, Selke S, Magaret A, Boeckh M. Impact of human cytomegalovirus (CMV)  infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults. J Med Virol. 2013 Sep; 85(9):1557-60.

252. Wheldon CW, Buhi ER, Daley EM. Gay and bisexual men's human papillomavirus vaccine intentions: A theory-based structural equation analysis. J Health Psychol. 2013 Sep; 18(9):1177-86.

253. Wichmann O, Ultsch B. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1260-9.

254. Williams SE, Rothman RL, Offit PA, Schaffner W, Sullivan M, Edwards KM. A randomized trial to increase acceptance of childhood vaccines by vaccine-hesitant parents: a pilot study. Acad Pediatr. 2013 Sep-Oct; 13(5):475-80

255. Wood RA. Allergic reactions to vaccines. Pediatr Allergy Immunol. 2013 Sep;24(6):521-6.

256. Wright TH, Brooks AE, Didsbury AJ, Williams GM, Harris PW, Dunbar PR, Brimble MA. Direct Peptide Lipidation through Thiol-Ene Coupling Enables Rapid Synthesis and Evaluation of Self-Adjuvanting Vaccine Candidates. Angew Chem Int Ed Engl. 2013 Sep 27; 52(40):10616-9.

257. Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D, Consigny PH; GEVACCIM. Persistence of yellow Fever vaccine-induced antibodies after solid organ transplantation. Am J Transplant. 2013 Sep;13(9):2458-61.

258. Xu Y, Wang L, Xu J, Wang X, Wei C, Luo P, Ma X, Hou Q, Wang J. Seroprevalence of pertussis in China: Need to improve vaccination strategies. Hum Vaccin Immunother. 2013 Sep 9; 10(1). [Epub ahead of print].

259. Yang WH, Dionne M, Kyle M, Aggarwal N, Li P, Madariaga M, Godeaux O, Vaughn  DW. Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial. Vaccine. 2013 Sep 13; 31(40):4389-97.

260. Yuet Sheung Yuen C, Yee Tak Fong D, Lai Yin Lee I, Chu S, Sau-Mei Siu E, Tarrant M. Prevalence and predictors of maternal seasonal influenza vaccination in Hong Kong. Vaccine. 2013 Sep 7. [Epub ahead of print].

261. Yusuf M, Konc J, Sy Bing C, Trykowska Konc J, Ahmad Khairudin NB, Janezic D, Wahab HA. Structurally Conserved Binding Sites of Hemagglutinin as Targets for Influenza Drug and Vaccine Development. J Chem Inf Model. 2013 Sep 13. [Epub ahead of print].

262. Zapata JC, Carrion R Jr, Patterson JL, Crasta O, Zhang Y, Mani S, Jett M, Poonia B, Djavani M, White DM, Lukashevich IS, Salvato MS. Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate. PLoS Negl Trop Dis. 2013 Sep 12; 7(9):e2406.

263. Zhou L, Su Q, Xu Z, Feng A, Jin H, Wang S, Feng Z. Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in china by season (2009/10 to 2011/12). PLoS One. 2013 Sep 9; 8(9):e73724.

264. Zhou P, Xie J. Comparative genomics of the Mycobacterium signaling architecture and implications for a novel live attenuated Tuberculosis vaccine. Hum Vaccin Immunother. 2013 Sep 6; 10(1). [Epub ahead of print].

265. Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, Harris S, Neal JW, Love S, Nicoll JA, Boche D. Inflammatory components in human Alzheimer's disease  and after active amyloid-β42 immunization. Brain. 2013 Sep; 136(Pt 9):2677-96.

[Top]